New York, NY -- (SBWIRE) -- 01/23/2014 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: AirMedia Group Inc (ADR) (NASDAQ:AMCN), Avalon Rare Metals Inc (US listing) (NYSEMKT:AVL), Affymetrix, Inc (NASDAQ:AFFX), Threshold Pharmaceuticals, Inc (NASDAQ:THLD)
AirMedia Group Inc (ADR) (NASDAQ:AMCN) showed a volume of 1.37 million shares by the end of last trade whereas the average volume of the stock remained 785,874 shares. The stock opened the session at $2.50 but then moved to 2.39. At that price, the stock showed a positive performance of 2.14%. AirMedia Group Inc is a holding company. The Company is an operator of out-of-home advertising platforms in China. As of March 1, 2012, the Company operated approximately 3,368 digital frames in 34 airports, 1,367 of which were standalone digital frames,
Will AMCN Continue To Move Higher? Find Out Here
Avalon Rare Metals Inc (US listing) (NYSEMKT:AVL) opened the session at $0.53 and closed the session at $0.582. The stock showed a positive performance of 9.01% in previous trading session. Traded with volume of 1.35 million shares in the prior session and the average volume of the stock remained 712,818.00 shares. Avalon Rare Metals Inc. (Avalon) is a Canada-based mineral exploration and development company. The Company’s primary focus is on rare metals and minerals, including tin, lithium, tantalum, niobium, cesium, indium, gallium, zirconium and calcium feldspar.
For How Long AVL will fight for Profitability? Read This Trend Analysis report
Affymetrix, Inc (NASDAQ:AFFX) opened the session at $9.33 and closed the session at $9.31. Traded with volume of 1.34 million shares in the prior session and the average volume of the stock remained 1.23 million shares. The beta of the stock remained 1.70. Affymetrix, Inc. (Affymetrix) is engaged in the development, manufacture, sale and service of consumables and systems for genetic analysis in the life sciences and clinical healthcare markets. Affymetrix has developed its GeneChip system and related microarray technology as a platform for acquiring, analyzing and managing genetic information.
Is AFFX a Solid Investment at These Levels? Read This Report For Details
Threshold Pharmaceuticals, Inc (NASDAQ:THLD) the stock advanced 4.76% and finished the session at $5.72. Traded with volume of 1.33 million shares in the prior session and the average volume of the stock remained 512,563 shares. The beta of the stock remained 1.15. Threshold Pharmaceuticals, Inc. is a biotechnology company focused on the discovery and development of drugs targeting the microenvironment of solid tumors and the bone marrows of some hematologic malignancies (blood cancers) as treatments for patients living with cancer.
Will THLD Continue To Move Higher? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)